-
Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry studyA Ghimire, N Fine, FA McAlister et al. -
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Pieske B Tschöpe C, de Boer RA et al.
-
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HFMartinez FA, Serenelli M, Nicolau JC et al.
-
Heart Failure and Atrial Fibrillation, Like Fire and FuryMA Carlisle, M Fudim, AD DeVore et al.
-
Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesSD Wiviott，I Raz，DECLARE–TIMI 58 Investigators.
-
Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionMcMurray JJV, SD Solomon, DAPA-HF Committees and Investigators.
-
Association of Left Ventricular Systolic Function With Incident Heart Failure in Late LifeAMR Jensen, R Zierath, B Claggett et al.
-
Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection FractionGoyal P, Paul T, Almarzooq ZI et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
